Schedule 13G ownership disclosure

INSYS THERAPEUTICS INC

Security class unavailable · CUSIP: 45824V209

Event date: 2019-03-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,976,671
Percent of class
8.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001615774-19-003718
Form type
SC 13G/A
Filer
ETF MANAGERS GROUP, LLC
CIK
CIK 1645173
Filed
Mar 07, 2019
Reporting period
Mar 06, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub